They express XCR1, TLR3 and CLEC9A and exhibit a high cross‐presentation potential of exogenous antigens through MHC class I21 hence inducing efficient CD8+ cytotoxic T‐cell responses against infected or tumor cells. The gene discussed is CLEC9A; the disease is neoplasm.